BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32739965)

  • 1. Molecular Alterations in Vaginal Melanomas: Report of 4 Cases and Literature Review.
    Moran JMT; Fujimoto M; Iwahashi Y; Cornejo KM; Hoang MP
    Am J Dermatopathol; 2021 Jan; 43(1):45-48. PubMed ID: 32739965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center Study.
    Rouzbahman M; Kamel-Reid S; Al Habeeb A; Butler M; Dodge J; Laframboise S; Murphy J; Rasty G; Ghazarian D
    J Low Genit Tract Dis; 2015 Oct; 19(4):350-3. PubMed ID: 26225944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site.
    Zarei S; Voss JS; Jin L; Jenkins SM; Bryce AH; Erickson LA; Bell DA; Kipp BR; Flotte TJ
    Int J Gynecol Pathol; 2020 Nov; 39(6):587-594. PubMed ID: 31567539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
    Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
    Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal melanoma in Denmark from 1980 to 2018: A population-based study based on genetic profile and survival.
    Yazdanfard NW; Mikkelsen LH; Behrendt N; Fuglsang K; Blaakær J; Hölmich LR; Frøding LP; Munch-Petersen HF; Heegaard S
    Gynecol Oncol; 2022 Apr; 165(1):53-59. PubMed ID: 35123773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands.
    van Engen-van Grunsven AC; Küsters-Vandevelde HV; De Hullu J; van Duijn LM; Rijntjes J; Bovée JV; Groenen PJ; Blokx WA
    Gynecol Oncol; 2014 Jul; 134(1):10-4. PubMed ID: 24802725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
    Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
    Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of vulvar and vaginal melanomas: current and future strategies.
    Leitao MM
    Am Soc Clin Oncol Educ Book; 2014; ():e277-81. PubMed ID: 24857113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SF3B1, NRAS, KIT, and BRAF Mutation; CD117 and cMYC Expression; and Tumoral Pigmentation in Sinonasal Melanomas: An Analysis With Newly Found Molecular Alterations and Some Population-Based Molecular Differences.
    Wroblewska JP; Mull J; Wu CL; Fujimoto M; Ogawa T; Marszalek A; Hoang MP
    Am J Surg Pathol; 2019 Feb; 43(2):168-177. PubMed ID: 30273197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
    Antonescu CR; Busam KJ; Francone TD; Wong GC; Guo T; Agaram NP; Besmer P; Jungbluth A; Gimbel M; Chen CT; Veach D; Clarkson BD; Paty PB; Weiser MR
    Int J Cancer; 2007 Jul; 121(2):257-64. PubMed ID: 17372901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population.
    Yilmaz I; Gamsizkan M; Kucukodaci Z; Berber U; Demirel D; Haholu A; Narli G
    Indian J Pathol Microbiol; 2015; 58(3):279-84. PubMed ID: 26275246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic characterization of tumors of the vulva and vagina.
    Micci F; Teixeira MR; Scheistrøen M; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2003 Oct; 38(2):137-48. PubMed ID: 12939741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary malignant melanoma of the vagina: case report and review of literature.
    Piura B; Rabinovich A; Yanai-Inbar I
    Eur J Gynaecol Oncol; 2002; 23(3):195-8. PubMed ID: 12094953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Vaginal Melanoma, A Rare and Aggressive Entity. A Case Report and Review of the Literature.
    Kalampokas E; Kalampokas T; Damaskos C
    In Vivo; 2017 Jan; 31(1):133-139. PubMed ID: 28064232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary malignant melanoma of the female genital tract.
    Gungor T; Altinkaya SO; Ozat M; Bayramoglu H; Mollamahmutoglu L
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):169-75. PubMed ID: 19574182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF mutations might be more common than supposed in vulvar melanomas.
    Wylomanski S; Denis MG; Théoleyre S; Bouquin R; Vallée A; Knol AC; Saint-Jean M; Peuvrel L; Dréno B; Quéreux G
    Exp Dermatol; 2018 Feb; 27(2):210-213. PubMed ID: 29178146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
    Hintzsche JD; Gorden NT; Amato CM; Kim J; Wuensch KE; Robinson SE; Applegate AJ; Couts KL; Medina TM; Wells KR; Wisell JA; McCarter MD; Box NF; Shellman YG; Gonzalez RC; Lewis KD; Tentler JJ; Tan AC; Robinson WA
    Melanoma Res; 2017 Jun; 27(3):189-199. PubMed ID: 28296713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.